Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Sistema d'Avaluació de símptomes d'Edmonton (ESAS)× | Escala d'Avaluació de Símptomes Memorial (MSAS)× | |
|---|---|---|
| Camp | Infermeria oncològica | Infermeria oncològica |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 1991 | 1994 |
| Autor original≠ | Eduardo Bruera | Russell Portenoy |
| Tipus≠ | Patient self-report multisymptom palliative care scale | Patient self-report multisymptom prevalence and distress scale |
| Font seminal≠ | Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6–9. DOI ↗ | Portenoy, R. K., Thaler, H. T., Kornblith, A. B., et al. (1994). The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer, 30A(9), 1326–1336. DOI ↗ |
| Àlies | ESAS, Edmonton Symptom Assessment Scale | MSAS, MSAS-SF |
| Relacionats | 4 | 4 |
| Resum≠ | The Edmonton Symptom Assessment System is a rapid, validated 9-item tool that assesses the severity of common symptoms in cancer and palliative care patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite loss, general well-being, and shortness of breath. Developed by Bruera and colleagues at the University of Alberta in 1991, the ESAS has become the standard symptom-screening instrument in oncology clinics, palliative care units, and end-of-life care settings worldwide, enabling efficient symptom prioritization and management escalation. | The Memorial Symptom Assessment Scale is a comprehensive multisymptom instrument that captures both prevalence and distress of 32 cancer-related symptoms (full version) or 10 core symptoms (short form). Developed by Portenoy and colleagues at Memorial Sloan Kettering Cancer Center in 1994, the MSAS is designed for detailed symptom profiling in oncology research and clinical practice, enabling identification of symptom clusters and assessment of physical and psychological symptom burden separately. |
| ScholarGateConjunt de dades ↗ |
|
|